30-day FRN

53510

Federal Register / Vol. 82, No. 220 / Thursday, November 16, 2017 / Notices

further develop and evaluate, please
contact Cecilia Pazman, Ph.D.,
Technology Development Specialist,
Office of Technology Transfer, National
Heart, Lung, and Blood Institute, Phone:
(301) 594–4273; pazmance@
nhlbi.nih.gov .
Dated: November 6, 2017.
Michael Shmilovich,
Senior Licensing and Patenting Manager,
National Heart, Lung, and Blood Institute,
Office of Technology Transfer and
Development.
[FR Doc. 2017–24773 Filed 11–15–17; 8:45 am]

Place: National Institutes of Health, 5601
Fishers Lane, Rockville, MD 20892
(Telephone Conference Call).
Contact Person: Dharmendar Rathore,
Ph.D., Senior Scientific Review Officer,
Scientific Review Program, Division of
Extramural Activities, Room 3G30, National
Institutes of Health/NIAID, 5601 Fishers
Lane, MSC 9823, Bethesda, MD 20892–9823,
240–669–5058, [email protected].
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: November 9, 2017.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.

BILLING CODE 4140–01–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

[FR Doc. 2017–24762 Filed 11–15–17; 8:45 am]
BILLING CODE 4140–01–P

National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meetings

asabaliauskas on DSKBBXCHB2PROD with NOTICES

Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel, Dysregulation of Immune
Cell Regulatory Pathways by MTB in the
Context of HIV Infection (R61/R33).
Date: December 11–12, 2017.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 5601
Fishers Lane, Rockville, MD 20892
(Telephone Conference Call).
Contact Person: J. Bruce Sundstrom, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
Room 3G11A, National Institutes of Health/
NIAID, 5601 Fishers Lane, MSC 9823,
Bethesda, MD 20892–9823, 240–669–5045,
[email protected].
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel, Global Infectious Disease
Research Administration Development
Award For Low-And Middle-Income Country
Institutions (G11).
Date: December 13, 2017.
Time: 1:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.

VerDate Sep<11>2014

16:52 Nov 15, 2017

Jkt 244001

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-Day
Comment Request; NCI Cancer
Genetics Services Directory WebBased Application and Update Mailer
(National Cancer Institute)
AGENCY:

National Institutes of Health,

HHS.
ACTION:

Notice.

In compliance with the
Paperwork Reduction Act of 1995, the
National Institutes of Health (NIH) has
submitted to the Office of Management
and Budget (OMB) a request for review
and approval of the information
collection listed below.
DATES: Comments regarding this
information collection are best assured
of having their full effect if received
within 30-days of the date of this
publication.
ADDRESSES: Written comments and/or
suggestions regarding the item(s)
contained in this notice, especially
regarding the estimated public burden
and associated response time, should be
directed to the: Office of Management
and Budget, Office of Regulatory Affairs,
[email protected] or by
fax to 202–395–6974, Attention: Desk
Officer for NIH.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the data collection plans and
instruments, contact: Margaret
Beckwith, Office of Cancer Content,
Office of Communications and Public
Liaison (OCPL), 9609 Medical Center
Drive, Rockville, MD 20892 or call nontoll-free number 240–276–6600 or email
SUMMARY:

PO 00000

Frm 00061

Fmt 4703

Sfmt 4703

your request, including your address to:
[email protected].
SUPPLEMENTARY INFORMATION: This
proposed information collection was
previously published in the Federal
Register on September 5, 2017 page
41971 (82 FR 41971) and allowed 60
days for public comment. No public
comments were received. The purpose
of this notice is to allow an additional
30 days for public comment. The
National Cancer Institute (NCI),
National Institutes of Health, may not
conduct or sponsor, and the respondent
is not required to respond to, an
information collection that has been
extended, revised, or implemented on or
after October 1, 1995, unless it displays
a currently valid OMB control number.
In compliance with Section
3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National
Institutes of Health (NIH) has submitted
to the Office of Management and Budget
(OMB) a request for review and
approval of the information collection
listed below.
Proposed Collection: NCI Cancer
Genetics Services Directory Web-Based
Application and Update Mailer, 0925–
0639, Exp., date 10/31/2017,
Reinstatement without change, National
Cancer Institute (NCI), National
Institutes of Health (NIH).
Need and Use of Information
Collection: The Office of
Communications and Public Liaison has
created the NCI Cancer Genetics
Services Directory on NCI’s Web site
Cancer.gov. This directory is a
searchable collection of information
about professionals who provide
services related to cancer genetics.
These services include cancer risk
assessment, genetic counseling, and
genetic susceptibility testing. The
professionals have applied to be in the
directory using an online application
form and have met basic criteria
outlined on the form.
There are currently 552 genetics
professionals listed in the directory.
Approximately 30–60 new professionals
are added to the directory each year.
The applicants are nurses, physicians,
genetic counselors, and other
professionals who provide services
related to cancer genetics. The
information collected on the application
form includes name, professional
qualifications, practice locations, and
the area of specialization. The
information is updated annually using a
Web-based update mailer that mirrors
the application form.
The NCI Cancer Genetics Services
Directory is a unique resource for cancer
patients and their families who are

E:\FR\FM\16NON1.SGM

16NON1

53511

Federal Register / Vol. 82, No. 220 / Thursday, November 16, 2017 / Notices
looking for information about their
family risk of cancer and genetic
counseling. Collecting applicant
information and verifying it annually by
using the NCI Cancer Genetics Services

Directory Web-based Application Form
and Update Mailer is important for
providing this information to the public
and for keeping it current.

OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The total
estimated annualized burden hours are
180.

ESTIMATED ANNUALIZED BURDEN HOURS

Web-based Application Form ............
Web-based Update Mailer ................

Genetics Professional ......................
Genetics Professional ......................

60
600

1
1

30/60
15/60

30
150

Totals ..........................................

..........................................................

660

660

........................

180

purpose of this notice is to insert the
expiration date and should read;
Proposed Collection: Generic Clearance
to Support the Safe to Sleep® Campaign
0925–0701, Expiration Date 07/31/2017,
REINSTATEMENT WITH CHANGE at
the Eunice Kennedy Shriver National
Institute for Child Health and Human
Development (NICHD), National
Institutes of Health (NIH).

[FR Doc. 2017–24786 Filed 11–15–17; 8:45 am]
BILLING CODE 4140–01–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-Day
Comment Request; Generic Clearance
To Support the Safe To Sleep®
Campaign (Eunice Kennedy Shriver
National Institute of Child Health and
Human Development); Correction
AGENCY:
ACTION:

Dated: November 9, 2017.
Jennifer Guimond,
Project Clearance Liaison, Eunice Kennedy
Shriver National Institute of Child Health and
Human Development, National Institutes of
Health.
[FR Doc. 2017–24776 Filed 11–15–17; 8:45 am]
BILLING CODE 4140–01–P

National Institutes of Health,

HHS.

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

Notice; correction.

The Department of Health and
Human Services, National Institutes of
Health published a Notice in the
Federal Register on November 9, 2017.
That Notice inadvertently contained an
error in the SUPPLEMENTARY INFORMATION
section.
FOR FURTHER INFORMATION CONTACT: Dr.
Jennifer Guimond, Project Clearance
Liaison, Office of Science Policy,
Reporting, and Program Analysis,
Eunice Kennedy Shriver National
Institute of Child Health and Human
Development, National Institutes of
Health, 31 Center Drive, Room 2A18,
Bethesda, Maryland 20892 or call nontoll-free number (301) 496–1877 or
Email [email protected].
SUPPLEMENTARY INFORMATION: On
November 9, 2017, the Department of
Health and Human Services, National
Institutes of Health published a Notice
in the Federal Register on page 52062
(82 FR 52062) that inadvertently did not
contain the expiration date within the
SUPPLEMENTARY INFORMATION section
regarding Proposed Collection:. The
SUMMARY:

asabaliauskas on DSKBBXCHB2PROD with NOTICES

Average
burden
per response
(in hours)

Type of
respondent

Dated: November 7, 2017.
Karla Bailey,
Project Clearance Liaison, National Cancer
Institute, National Institutes of Health.

Number of
respondents

Number of
responses per
respondent

Form name

VerDate Sep<11>2014

16:52 Nov 15, 2017

Jkt 244001

Total annual
burden hours

Health, 31 Center Drive, Room 2A18,
Bethesda, Maryland 20892 or call nontoll-free number (301) 496–1877 or
Email [email protected].
SUPPLEMENTARY INFORMATION: On
November 9, 2017, the Department of
Health and Human Services, National
Institutes of Health published a Notice
in the Federal Register on page 52067
(82 FR 52067) that inadvertently
contained an error in the date of
expiration. The purpose of this notice is
to correct the expiration date to read:
10/31/2017.
Dated: November 9, 2017.
Jennifer Guimond,
Project Clearance Liaison, Eunice Kennedy
Shriver National Institute of Child Health and
Human Development, National Institutes of
Health.
[FR Doc. 2017–24775 Filed 11–15–17; 8:45 am]
BILLING CODE 4140–01–P

National Institutes of Health
Submission for OMB Review; 30-Day
Comment Request; Generic Clearance
for the Collection of Qualitative
Feedback on Agency Service Delivery
(Eunice Kennedy Shriver National
Institute of Child Health and Human
Development); Correction
AGENCY:

National Institutes of Health,

HHS.
ACTION:

Notice; correction.

The Department of Health and
Human Services, National Institutes of
Health published a Notice in the
Federal Register on November 9, 2017.
That Notice inadvertently contained an
error in the SUPPLEMENTARY INFORMATION
section.
FOR FURTHER INFORMATION CONTACT: Dr.
Jennifer Guimond, Project Clearance
Liaison, Office of Science Policy,
Reporting, and Program Analysis,
Eunice Kennedy Shriver National
Institute of Child Health and Human
Development, National Institutes of
SUMMARY:

PO 00000

Frm 00062

Fmt 4703

Sfmt 4703

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR 16–

E:\FR\FM\16NON1.SGM

16NON1